Caption Management’s Immunocore IMCR Stock Holding History

Caption Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	60,000 +30,000	+100%	+$887K	0.01%	921
2026 Q1	$905K	Buy	+30,000	New	+$971K	0.01%	1052
2025 Q4	–	Sell	-64,400	Closed	-$2.34M	–	1811
2025 Q3	$2.34M	Buy	+64,400	New	+$2.19M	0.02%	784
2025 Q2	–	Sell	-27,500	Closed	-$816K	–	1669
2025 Q1	$816K	Buy	+27,500	New	+$825K	0.01%	974
2024 Q4	–	Sell	-12,500	Closed	-$389K	–	1624
2024 Q3	$389K	Buy	+12,500	New	+$455K	0.01%	971
2024 Q2	–	Sell	-162,000	Closed	-$10.5M	–	1321
2024 Q1	$10.5M	Buy	+162,000	New	+$11.1M	0.16%	152

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Caption Management's IMCR Position: Q2 2026 in Review

Caption Management reduced its Immunocore (IMCR) stake by 74% in Q2 2026, selling an estimated $14.5M and leaving 172,503 shares worth $5.48M. The position accounts for 0.03% of the portfolio, ranked #558.

Caption Management first reported a position in IMCR in Q4 2022 and has held it in 8 quarters since. The position peaked at $20M in Q1 2026. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Caption Management held 172,503 shares of Immunocore worth $5.48M as of Q2 2026.
Caption Management sold 489,283 Immunocore shares in Q2 2026, an estimated $14.5M.
Immunocore made up 0.03% of Caption Management's portfolio in Q2 2026, its #558 holding.
Caption Management first reported a position in Immunocore in Q4 2022 and has held it in 8 quarters since.
Caption Management's Immunocore position peaked at $20M in Q1 2026.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.